https://9krapalm.com/mingmed-biotechnology-presents-positive-phase-ii-data-of-oral-qa102-for-the-treatment-of-intermediate-age-related-macular-degeneration-amd-at-association-for-research-in-vision-and-ophthalmology-ar/
MingMed Biotechnology Presents Positive Phase II Data of Oral QA102 for the Treatment of...
GUANGZHOU, China, May 6, 2026 /PRNewswire/ -- MingMed Biotechnology Co., Ltd, a biomedical firm focused on the discovery and development of novel